EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis

Yosuke Osawa iD, Hironari Kawai, Keigo Nakashima, Yuichi Nakaseko, Daisuke Suto, Keisuke Yanagida, Tomomi Hashidate-Yoshida, Taizo Mori, Sachiyo Yoshio, Takaaki Ohtake, Hideo Shindou, Tatsuya Kanto

PLOS ONE · 16.05.2024 · 19 (5) · e0303296

DOI: 10.1371/journal.pone.0303296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 16.05.2024. Verfasst von Yosuke Osawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Gastroenterology, International University of Health and Welfare Hospital, Tochigi, Japan. Hauptthemen laut MEDLINE: Sphingosine, Lysophospholipids, Liver Cirrhosis, Hepatic Stellate Cells. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, IUHW Research Grant, the Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Metabolic dysfunction-associated steatohepatitis (MASH) is one of the most prevalent liver diseases and is characterized by steatosis and the accumulation of bioactive lipids. This study aims to understand the specific lipid species responsible for the progression of liver fibrosis in MASH.

Methods

Changes in bioactive lipid levels were examined in the livers of MASH mice fed a choline-deficient diet (CDD). Additionally, sphingosine kinase (SphK)1 mRNA, which generates sphingosine 1 phosphate (S1P), was examined in the livers of patients with MASH.

Results

CDD induced MASH and liver fibrosis were accompanied by elevated levels of S1P and increased expression of SphK1 in capillarized liver sinusoidal endothelial cells (LSECs) in mice. SphK1 mRNA also increased in the livers of patients with MASH. Treatment of primary cultured mouse hepatic stellate cells (HSCs) with S1P stimulated their activation, which was mitigated by the S1P receptor (S1PR)2 inhibitor, JTE013. The inhibition of S1PR2 or its knockout in mice suppressed liver fibrosis without reducing steatosis or hepatocellular damage.

Conclusion

S1P level is increased in MASH livers and contributes to liver fibrosis via S1PR2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SphingosineLysophospholipidsLiver CirrhosisHepatic Stellate CellsPhosphotransferases (Alcohol Group Acceptor)Sphingosine-1-Phosphate ReceptorsFatty LiverAnimalsMiceHumansMaleMice, KnockoutMice, Inbred C57BLLiverCholine DeficiencyEndothelial CellsReceptors, LysosphingolipidPyrazolesPyridinesSphingosine Kinase

Substanzen

SphingosineLysophospholipidsPhosphotransferases (Alcohol Group Acceptor)Sphingosine-1-Phosphate ReceptorsReceptors, LysosphingolipidPyrazolesPyridinesSphingosine Kinasesphingosine 1-phosphateSphk1 protein, mouse

Autor:innen und Institutionen

  • Departments of Gastroenterology, International University of Health and Welfare Hospital, Tochigi, Japan.
  • Department of Liver Diseases, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan.
  • Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Departments of Surgery, International University of Health and Welfare Hospital, Tochigi, Japan.
  • Departments of Lipid Life Science, National Center for Global Health and Medicine, Tokyo, Japan.
  • Departments of Medical Lipid Science, Graduated Scholl of Medicine, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Yosuke Osawa

Förderung

  • JSPS KAKENHI
  • IUHW Research Grant
  • the Japan Agency for Medical Research and Development
  • the National Center for Global Health and Medicine, Intramural Research Fund
  • Grant-in-Aid for Research from the National Center for Global Health and Medicine

Zitieren

APA

Osawa, Y., Kawai, H., Nakashima, K., Nakaseko, Y., Suto, D., Yanagida, K., Hashidate-Yoshida, T., Mori, T., Yoshio, S., Ohtake, T., Shindou, H., & Kanto, T. (2024). Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis. PLOS ONE, 19(5), e0303296. https://doi.org/10.1371/journal.pone.0303296

Vancouver

Osawa Y, Kawai H, Nakashima K, Nakaseko Y, Suto D, Yanagida K, et al. Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis. PLOS ONE. 2024;19(5):e0303296. doi:10.1371/journal.pone.0303296

BibTeX
@article{Osawa2024,
  author = {Osawa, Yosuke and Kawai, Hironari and Nakashima, Keigo and Nakaseko, Yuichi and Suto, Daisuke and Yanagida, Keisuke and Hashidate-Yoshida, Tomomi and Mori, Taizo and Yoshio, Sachiyo and Ohtake, Takaaki and Shindou, Hideo and Kanto, Tatsuya},
  title = {Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {5},
  pages = {e0303296},
  doi = {10.1371/journal.pone.0303296}
}
Kostenlos starten →